Physician profile
Jared H Mathis
NPI 1497908008
$4,319.54
in general payments reported to CMS, 2019-2025
34 companies · $1,204 in 2025
The $1,204 reported for 2025 was more than what 83% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $522 · 2022: $1,009 · 2023: $830 · 2024: $755 · 2025: $1,204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,788.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,016.23 | 2021-2025 | Intellis Adaptivestim, Vanta Adaptivestim, Inceptiv |
| Abbvie INC. | $594.05 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $496.24 | 2021-2025 | Belbuca, Xtampza |
| Lundbeck LLC | $328.40 | 2022-2025 | Vyepti |
| Globus Medical, INC. | $264.73 | 2025 | Senza |
| Boston Scientific Corporation | $213.37 | 2022-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Pfizer INC. | $205.78 | 2021-2025 | |
| Averitas Pharma INC. | $131.17 | 2023-2024 | Qutenza |
| Biotronik Nro, INC. | $110.45 | 2025 | Prospera |
| Nalu Medical, INC. | $90.01 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $77.81 | 2022-2024 | Relistor |
| Amgen INC. | $74.46 | 2022-2024 | Prolia, Evenity |
| Vertex Pharmaceuticals Incorporated | $73.38 | 2024-2025 | |
| Abbott Laboratories | $65.95 | 2021-2025 | Eterna, Proclaim |
| Indivior INC. | $64.02 | 2021-2025 | Sublocade |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $59.21 | 2021-2022 | |
| Almatica Pharma LLC | $55.21 | 2021-2023 | Gralise |
| Braeburn INC. | $52.67 | 2025 | Brixadi |
| Biohaven Pharmaceuticals, INC. | $47.39 | 2021 | |
| Relievant Medsystems, INC. | $39.28 | 2022-2023 | Intracept |
| Grt US Holding, INC. | $31.47 | 2022 | |
| Idorsia Pharmaceuticals US INC | $31.38 | 2023 | Quviviq |
| Teva Pharmaceuticals USA, INC. | $28.35 | 2022 | |
| Avanos Medical | $21.36 | 2025 | Generator |
| Spr Therapeutics, INC | $19.89 | 2022 | |
| Axsome Therapeutics, INC. | $18.41 | 2025 | Symbravo |
| Biodelivery Sciences International, INC. | $18.22 | 2021 | |
| Abiomed | $16.40 | 2024 | Impella |
| Allergan, INC. | $16.23 | 2022 | |
| Lilly USA, LLC | $13.08 | 2022 | |
| Horizon Therapeutics Plc | $12.84 | 2022 | |
| Supernus Pharmaceuticals, INC. | $12.56 | 2022 | |
| Redhill Biopharma INC. | $11.52 | 2021 | |
| Stimwave Technologies Incorporated | $8.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jared Mathis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.